EP1185290A4 - Manufacturing method for intravenous immune globulin and resultant product - Google Patents

Manufacturing method for intravenous immune globulin and resultant product

Info

Publication number
EP1185290A4
EP1185290A4 EP00942627A EP00942627A EP1185290A4 EP 1185290 A4 EP1185290 A4 EP 1185290A4 EP 00942627 A EP00942627 A EP 00942627A EP 00942627 A EP00942627 A EP 00942627A EP 1185290 A4 EP1185290 A4 EP 1185290A4
Authority
EP
European Patent Office
Prior art keywords
manufacturing
resultant product
immune globulin
intravenous immune
intravenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00942627A
Other languages
German (de)
French (fr)
Other versions
EP1185290A1 (en
Inventor
Raja R Mamidi
Andranik Bagdasarian
Gorgonio Canaveral
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grifols Shared Services North America Inc
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of EP1185290A1 publication Critical patent/EP1185290A1/en
Publication of EP1185290A4 publication Critical patent/EP1185290A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
EP00942627A 1999-06-15 2000-06-06 Manufacturing method for intravenous immune globulin and resultant product Withdrawn EP1185290A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US333289 1994-11-02
US33328999A 1999-06-15 1999-06-15
PCT/US2000/011870 WO2000076534A1 (en) 1999-06-15 2000-06-06 Manufacturing method for intravenous immune globulin and resultant product

Publications (2)

Publication Number Publication Date
EP1185290A1 EP1185290A1 (en) 2002-03-13
EP1185290A4 true EP1185290A4 (en) 2005-08-31

Family

ID=23302162

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00942627A Withdrawn EP1185290A4 (en) 1999-06-15 2000-06-06 Manufacturing method for intravenous immune globulin and resultant product

Country Status (13)

Country Link
EP (1) EP1185290A4 (en)
JP (1) JP2003501480A (en)
KR (1) KR20020010921A (en)
CN (1) CN1358100A (en)
AU (1) AU756071B2 (en)
BR (1) BR0011648A (en)
CA (1) CA2375560A1 (en)
CZ (1) CZ20014456A3 (en)
HK (1) HK1048252A1 (en)
IL (1) IL146433A0 (en)
PL (1) PL352910A1 (en)
WO (1) WO2000076534A1 (en)
ZA (1) ZA200110168B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2437518A (en) * 2006-04-26 2007-10-31 Noel Kavanagh Antiserum preparation
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
US7932356B1 (en) * 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
CN106414476B (en) * 2014-03-11 2019-12-31 株式会社绿十字控股 Method for purifying immunoglobulins
ES2785375T3 (en) 2014-03-11 2020-10-06 Green Cross Holdings Corp Immunoglobulin purification procedure
KR101941974B1 (en) * 2016-11-18 2019-01-24 주식회사 녹십자 Methods for Eliminating Factor XI during Plasma Protein Purification

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0413188A2 (en) * 1989-08-17 1991-02-20 Biotest Pharma Gmbh Method for producung an unmodified intravenous IgM- and/or IgA-containing immunoglobulin preparation
US5371196A (en) * 1990-10-05 1994-12-06 Jcr Pharmaceuticals Co., Ltd. Process for producing secretory immunoglobulin A preparations
DE4431833C1 (en) * 1994-09-07 1995-05-18 Blutspendedienst Der Drk Lande Prepn. of an anti-haemophilic factor from a cryo-precipitate
WO1999033484A1 (en) * 1997-12-24 1999-07-08 Alpha Therapeutic Corporation Production process for intravenous immune serum globulin and resultant product

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
FR2582515B1 (en) * 1985-05-30 1988-11-04 Merieux Inst PROCESS FOR THE PREPARATION OF GAMMA-GOBULINS ADMINISTRABLE BY THE INTRAVENOUS ROUTE AND GAMMA-GLOBULINS OBTAINED
JPH0662436B2 (en) * 1986-05-19 1994-08-17 株式会社ミドリ十字 Method for producing intravenous immunoglobulin preparation
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
US5110910A (en) * 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0413188A2 (en) * 1989-08-17 1991-02-20 Biotest Pharma Gmbh Method for producung an unmodified intravenous IgM- and/or IgA-containing immunoglobulin preparation
US5371196A (en) * 1990-10-05 1994-12-06 Jcr Pharmaceuticals Co., Ltd. Process for producing secretory immunoglobulin A preparations
DE4431833C1 (en) * 1994-09-07 1995-05-18 Blutspendedienst Der Drk Lande Prepn. of an anti-haemophilic factor from a cryo-precipitate
WO1999033484A1 (en) * 1997-12-24 1999-07-08 Alpha Therapeutic Corporation Production process for intravenous immune serum globulin and resultant product

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
F. GAO ET AL.: "Enhancement in the safety of immune globulins prepared from high-risk plasma.", VOX SANGUINIS, vol. 64, no. 4, 1993, Switzerland, pages 204 - 209, XP008036384 *
L. GÜRTLER: "Möglichkeiten der Virusinaktivierung von gepooltem Frischplasma mit Tri-n-butylphosphat-(TNBP-)Detergenz (SD-Verfahren) [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure).]", INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, vol. 21, no. suppl.1, August 1994 (1994-08-01), pages 77 - 79, XP008039494 *
See also references of WO0076534A1 *
Y. UEMURA ET AL.: "Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin.", VOX SANGUINIS, vol. 67, no. 3, October 1994 (1994-10-01), Switzerland, pages 246 - 254, XP000672116 *

Also Published As

Publication number Publication date
CA2375560A1 (en) 2000-12-21
BR0011648A (en) 2002-03-19
CN1358100A (en) 2002-07-10
AU756071B2 (en) 2003-01-02
EP1185290A1 (en) 2002-03-13
PL352910A1 (en) 2003-09-22
WO2000076534A1 (en) 2000-12-21
CZ20014456A3 (en) 2002-05-15
ZA200110168B (en) 2002-08-26
KR20020010921A (en) 2002-02-06
JP2003501480A (en) 2003-01-14
AU5722400A (en) 2001-01-02
IL146433A0 (en) 2002-07-25
HK1048252A1 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
HUP0101988A3 (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
EP0711658A3 (en) Multi-layer molded article and method for producing the same
GB2334263B (en) Hydrophilic article and method for producing same
HUP0202723A3 (en) Food product and process for manufacturing same
HUP9902841A3 (en) Catheter package and method for producing the same
HUP0001949A3 (en) Refastenable packing and process for manufacturing refastenable packing
PL361980A1 (en) Method for producing purified hematinic iron-saccharidic complex and product produced
EP0921542A4 (en) Chip inductor and method for manufacturing the same
EP1198184A4 (en) Appliqu method and article
EP1245379A4 (en) Laminate and process for producing the same
EP1262509A4 (en) Imide-benzoxazole polycondensate and process for producing the same
ZA9610555B (en) Sanitary article capable to improve fit against the body and method and apparatus for manufacturing same.
EP1426104A4 (en) Composite particulate article and method for preparation thereof
SG87105A1 (en) Column packing and method for manufacturing the same
GB2369352B (en) System and method for producing folded articles
AU6783700A (en) System and method for producing folded articles
IL131471A0 (en) Production process for intravenous immune serum globulin and resultant product
HK1025223A1 (en) Bifidobacterium-fermented milk and process for producing the same
HUP0104387A3 (en) Serigraphy reflection transfer product and method for producing the same
EP1176979A4 (en) High concentration immunoglobulin preparation and method for its production
HK1040421A1 (en) Ornament and method for preparation thereof
PL352910A1 (en) Manufacturing method for intravenous immune globulin and resultant product
HK1048889A1 (en) Component and method for the production thereof
HK1047655A1 (en) Semiconductor and manufacturing method for semiconductor
HUP0203443A3 (en) Novel contraceptive medicament and method for producing the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20011107;LT PAYMENT 20011107;LV PAYMENT 20011107;MK PAYMENT 20011107;RO PAYMENT 20011107;SI PAYMENT 20011107

A4 Supplementary search report drawn up and despatched

Effective date: 20050720

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PROBITAS PHARMA INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GRIFOLS INC.

17Q First examination report despatched

Effective date: 20060628

17Q First examination report despatched

Effective date: 20060628

17Q First examination report despatched

Effective date: 20060628

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070717